215 related articles for article (PubMed ID: 2217009)
1. Acanthosis nigricans in obese women with the polycystic ovary syndrome: disease spectrum not distinct entity.
Conway GS; Jacobs HS
Postgrad Med J; 1990 Jul; 66(777):536-8. PubMed ID: 2217009
[TBL] [Abstract][Full Text] [Related]
2. Association of acanthosis nigricans with insulin resistance in patients with polycystic ovary syndrome.
Panidis D; Skiadopoulos S; Rousso D; Ioannides D; Panidou E
Br J Dermatol; 1995 Jun; 132(6):936-41. PubMed ID: 7662572
[TBL] [Abstract][Full Text] [Related]
3. Role of obesity and hyperinsulinemia in the insulin resistance of obese subjects with the clinical triad of polycystic ovaries, hirsutism and acanthosis nigricans.
Wajchenberg BL; Giannella-Neto D; Lerario AC; Marcondes JA; Ohnuma LY
Horm Res; 1988; 29(1):7-13. PubMed ID: 3397043
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance and overweight-obese women with polycystic ovary syndrome.
Bhattacharya SM
Gynecol Endocrinol; 2010 May; 26(5):344-7. PubMed ID: 19903118
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance, acanthosis nigricans, and polycystic ovaries associated with a circulating inhibitor of postbinding insulin action.
Harrison LC; Dean B; Peluso I; Clark S; Ward G
J Clin Endocrinol Metab; 1985 May; 60(5):1047-52. PubMed ID: 3884647
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of insulin resistance in obese women with and without acanthosis nigricans.
Sadeghian G; Ziaie H; Amini M; Ali Nilfroushzadeh M
J Dermatol; 2009 Apr; 36(4):209-12. PubMed ID: 19348659
[TBL] [Abstract][Full Text] [Related]
7. Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia.
Dunaif A; Graf M; Mandeli J; Laumas V; Dobrjansky A
J Clin Endocrinol Metab; 1987 Sep; 65(3):499-507. PubMed ID: 3305551
[TBL] [Abstract][Full Text] [Related]
8. Spectrum of endocrine abnormalities associated with acanthosis nigricans.
Matsuoka LY; Wortsman J; Gavin JR; Goldman J
Am J Med; 1987 Oct; 83(4):719-25. PubMed ID: 3674058
[TBL] [Abstract][Full Text] [Related]
9. Glycosaminoglycan deposition in the acanthosis nigricans lesions of the polycystic ovary syndrome.
Wortsman J; Matsuoka LY; Kupchella CE; Gavin JR; Dietrich JG
Arch Intern Med; 1983 Jun; 143(6):1145-8. PubMed ID: 6344826
[TBL] [Abstract][Full Text] [Related]
10. Clinical and metabolic features of polycystic ovary syndrome among Chinese adolescents.
Li L; Chen X; He Z; Zhao X; Huang L; Yang D
J Pediatr Adolesc Gynecol; 2012 Dec; 25(6):390-5. PubMed ID: 23089573
[TBL] [Abstract][Full Text] [Related]
11. Bimodal correlation between the circulating insulin level and the production rate of dehydroepiandrosterone: positive correlation in controls and negative correlation in the polycystic ovary syndrome with acanthosis nigricans.
Farah MJ; Givens JR; Kitabchi AE
J Clin Endocrinol Metab; 1990 Apr; 70(4):1075-81. PubMed ID: 2138630
[TBL] [Abstract][Full Text] [Related]
12. Analysis of clinical characteristics in large-scale Chinese women with polycystic ovary syndrome.
Shi Y; Guo M; Yan J; Sun W; Zhang X; Geng L; Xu L; Chen Z
Neuro Endocrinol Lett; 2007 Dec; 28(6):807-10. PubMed ID: 18063948
[TBL] [Abstract][Full Text] [Related]
13. [Clinical features, hormonal profile, and metabolic abnormalities of obese women with obese polycystic ovary syndrome].
Li X; Lin JF
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(46):3266-71. PubMed ID: 16409817
[TBL] [Abstract][Full Text] [Related]
14. Adiponectin levels in women with polycystic ovary syndrome and severe insulin resistance.
Sepilian V; Nagamani M
J Soc Gynecol Investig; 2005 Feb; 12(2):129-34. PubMed ID: 15695109
[TBL] [Abstract][Full Text] [Related]
15. A syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans associated with polycystic ovary syndrome: clinical and laboratory features.
Taketani Y; Mizuno M
Horm Res; 1990; 33 Suppl 2():27-30. PubMed ID: 2095357
[TBL] [Abstract][Full Text] [Related]
16. Acanthosis nigricans in obese women with hyperandrogenism. Characterization of an insulin-resistant state distinct from the type A and B syndromes.
Flier JS; Eastman RC; Minaker KL; Matteson D; Rowe JW
Diabetes; 1985 Feb; 34(2):101-7. PubMed ID: 3881301
[TBL] [Abstract][Full Text] [Related]
17. Clinical, biochemical, and ovarian morphologic features in women with acanthosis nigricans and masculinization.
Dunaif A; Hoffman AR; Scully RE; Flier JS; Longcope C; Levy LJ; Crowley WF
Obstet Gynecol; 1985 Oct; 66(4):545-52. PubMed ID: 3900841
[TBL] [Abstract][Full Text] [Related]
18. Acromegaly with polycystic ovaries, hyperandrogenism, hirsutism, insulin resistance and acanthosis nigricans: a case report.
Unal A; Sahin Y; Keleştimur F
Endocr J; 1993 Apr; 40(2):207-11. PubMed ID: 7951506
[TBL] [Abstract][Full Text] [Related]
19. Significance of acanthosis nigricans in childhood obesity.
Guran T; Turan S; Akcay T; Bereket A
J Paediatr Child Health; 2008 Jun; 44(6):338-41. PubMed ID: 18476925
[TBL] [Abstract][Full Text] [Related]
20. Insulin, somatotropic, and luteinizing hormone axes in lean and obese women with polycystic ovary syndrome: common and distinct features.
Morales AJ; Laughlin GA; Bützow T; Maheshwari H; Baumann G; Yen SS
J Clin Endocrinol Metab; 1996 Aug; 81(8):2854-64. PubMed ID: 8768842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
